GlaxoSmithKline Stock Performance
as on November 20, 2026 at 7:31 am IST
Day's Low
Day's High
$47.68$48.44
0.23%
Downside
1.36%
Upside

52 Week's Low
52 Week's High
$45.81$61.70
4.15%
Downside
29.10%
Upside

GlaxoSmithKline share price movements today
- Previous Close
- $48.58
- Open
- $48.28
- Volume
- 2.2M
- Market Cap
- $98.9B
- Dividend Yield
- 3.73%
- Day's Low - High
- $47.68 - $48.44
- 52 Week Low - High
- $45.81 - $61.70
GlaxoSmithKline Historical Returns
- 1 Month Return
- -1.78 %
- 3 Month Return
- -8.13 %
- 1 Year Return
- + 4.83 %
- 3 Year Return
- + 38.01 %
- 5 Year Return
- -6.55 %
GlaxoSmithKline Stock Fundamentals & Key Indicators
Check GlaxoSmithKline market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$98.9B
EPS (TTM)
2.16
Dividend Yield
3.73%
Quarterly Earnings Growth YOY
-0.23%
PE Ratio (TTM)
17.31
Industry PE ratio
9.71
PEG Ratio
-0.84
EBITDA
8.7B
Revenue (TTM)
33.5B
Profit Margin
73.52%
Return On Equity TTM
24.64%
GlaxoSmithKline vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of GlaxoSmithKline with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $98.9B | -6.55% | 17.31 | 73.52% | 3.73% | |
| StrongBuy | $1.3T | 430.40% | 45.54 | 83.63% | 0.49% | |
| StrongBuy | $517.6B | 146.05% | 50.06 | 73.72% | 2.36% | |
| Buy | $680.2B | 71.61% | 42.30 | 67.56% | 1.87% | |
| StrongBuy | $286.8B | 60.70% | 25.61 | 77.59% | 1.76% |
Stock Returns calculator for GlaxoSmithKline Stock including INR - Dollar returns
The GlaxoSmithKline stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
GlaxoSmithKline investment value today
Current value as on today
₹1,08,721
Returns
₹8,721
(+8.72%)
Returns from GlaxoSmithKline Stock
₹3,129 (+3.13%)
Dollar Impact
₹5,592 (+5.59%)
Analyst Recommendation on GlaxoSmithKline Stock
Based on 33 analysts
60.61%
Buy
30.30%
Hold
9.09%
Sell
Based on 33 analysts, 60.61% of analysts recommend a 'BUY' rating for GlaxoSmithKline. Average target price of $59.12
GlaxoSmithKline Share Price Target
Get share price movements and forecasts by analysts on GlaxoSmithKline.
What analysts predicted
19.16%UPSIDE
Target Price
$59.12
Current Price
$47.79
Analyzed by
33 Analysts
Target
$59.12
GlaxoSmithKline target price $59.12, a slight upside of 19.16% compared to current price of $47.79. According to 33 analysts rating.
Indian Investors' Interest in GlaxoSmithKline Stock
Search interest for GlaxoSmithKline Stock has increased by 66% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:66% versus previous 30 day period
GlaxoSmithKline Quarterly Profit & Loss
All numbers in Millions USD
GlaxoSmithKline Annual Profit & Loss
All numbers in Millions USD
GlaxoSmithKline Quarterly Cash Flow
All numbers in Millions USD
GlaxoSmithKline Annual Cash Flow
All numbers in Millions USD
GlaxoSmithKline News & Key Events

Today's Timeline - 17 November
Tue, 03:42 PM
-GSK targets £40 billion in sales by 2031, offsetting patent expirations with new medicines.
Tue, 09:34 PM
-GSK executives acquire shares through dividend reinvestment, signaling confidence in the company.
Tue, 10:01 PM
-GSK updates on COPD study, aiming to expand treatment options amid competitive market.

Today's Timeline - 17 November
Wed, 00:30 AM
-GSK receives FDA accelerated approval for Nelkarmi, a lung cancer treatment, ahead of the original target date.
Insights on GlaxoSmithKline
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich

GSK plc American Depositary Shares (ADS) have shown positive revenue performance over the last three quarters. The revenue increased from $7.62 billion to $8.81 billion, marking an average growth of 7.0% per quarter.
POSITIVE IMPACTProfit Spike

GSK plc American Depositary Shares have shown strong profit growth over the last two quarters. The net profit increased from $434.99 million to $1.53 billion, which represents an average increase of 71.6% per quarter.
POSITIVE IMPACTBest in 3 Years

In the last 3 years, GSK has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACTPrice Rise

In the last 3 years, GSK stock has moved up by 38.0%
NO EFFECTAgainst Peers

In the last 1 year, Merck & Co., Inc. has given 45.0% return, outperforming this stock by 40.2%
About GlaxoSmithKline
| Organisation | GlaxoSmithKline |
| Headquarters | 79 New Oxford Street, London, GL, WC1A 1DG, GB |
| Industry | Drug Manufacturers - General |
| CEO | Luke Victor Miels |
Key Management of GlaxoSmithKline
Name | Title |
|---|---|
Ms. Julie Belita Brown A.C.A. | CFO & Executive Director |
Dr. Jesse L. Goodman M.D., M.P.H. | Scientific & Medical Expert |
Mr. Jeff McLaughlin | VP of Investor Relations & Interim Head of Investor Relations |
Mr. David Simon Redfern BSc (Hons), CA | President of Corporate Development |
Mr. Philip C. Thomson | President of Global Affairs |
Mr. Luke Victor Miels | CEO & Director |
Ms. Shobie Ramakrishnan | Chief Digital & Technology Officer |
Mr. Tony Wood | Chief Scientific Officer and Head of R&D |
Mr. James Ford | Senior VP and Group General Counsel of Legal & Compliance |
Ms. Roanne Parry | Chief People Officer |
FAQs
What is GlaxoSmithKline share price today?
GlaxoSmithKline share price today is $47.79 as on . GlaxoSmithKline share today touched a day high of $48.44 and a low of $47.68.
What is the 52 week high and 52 week low for GlaxoSmithKline share?
GlaxoSmithKline share touched a 52 week high of $61.70 on and a 52 week low of $45.81 on . GlaxoSmithKline stock price today i.e. is trending at $47.79,which is 22.54% down from its 52 week high and 4.33% up from its 52 week low.
What is GlaxoSmithKline's market capitalisation today?
GlaxoSmithKline market capitalisation is $0.10T as on .
How to invest in GlaxoSmithKline Stock (GSK) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for GlaxoSmithKline on INDmoney app. Click on Buy button.
What is the minimum amount required to buy GlaxoSmithKline Stock (GSK) from India?
Indian investors can start investing in GlaxoSmithKline (GSK) shares with as little as ₹93.29000091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.90 in GlaxoSmithKline stock (as per the Rupee-Dollar exchange rate as on ).
Based on GlaxoSmithKline share’s latest price of $47.79 as on November 20, 2026 at 2:01 am IST, you will get 0.2092 shares of GlaxoSmithKline. Learn more about
fractional shares .
What are the returns that GlaxoSmithKline has given to Indian investors in the last 5 years?
GlaxoSmithKline stock has given -6.55% share price returns and 26.33% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?